Pam Wolters, Ph.D., Section Head
Pam Wolters, Ph.D., a licensed psychologist and staff scientist in the Pediatric Oncology Branch (POB) of the National Cancer Institute (NCI), is co-director of the Behavioral Sciences Core and head of the Neurobehavioral Program.
Dr. Wolters’ background includes a Ph.D. in School Psychology, internship in clinical child and pediatric psychology, post-doctoral fellowship in adolescent medicine, and post-doctoral training in neuropsychological research. Dr. Wolters has over 25 years experience in the developmental, cognitive, and psychological assessment of infants through adults, and she has specific expertise in working with pediatric populations with severe developmental disabilities and chronic medical conditions. She has been a licensed psychologist in the state of Maryland since 1994.
For her entire career, Dr. Wolters has worked at the NCI conducting neuropsychological research primarily with children, adolescents, and adults with chronic illnesses, such as cancer, HIV infection, and neurofibromatosis type 1 (NF1). Previously, she worked on all six of the competitive NCI neuropsychology contracts and served as the Principal Investigator of these contracts for 10 years during which she was responsible for all the technical aspects and appropriate scientific execution of the research program. Over the years, Dr. Wolters and the neuropsychology team developed a productive research agenda and an extensive publication record. She recently joined the POB in 2009 to lead the further development of collaborative neurobehavioral research and psychological services within the branch. Dr. Wolters works closely with the multidisciplinary team to design and implement collaborative studies, including several multi-center trials, to examine the longitudinal effects of disease and treatment on the central nervous system (CNS) and assess changes in quality of life (QOL). She also consults with staff, provides interventions, and recommends follow-up psychological services to help patients that have neurocognitive deficits, emotional concerns, and/or difficulty coping with medical procedures. Due to her expertise in research with pediatric medical conditions, Dr. Wolters is an invited peer reviewer for several respected scientific journals and various HIV and oncology grants, and she served as a consultant to develop the pediatric outcome measures for an international clinical trial. Furthermore, Dr. Wolters is an active participant in the NF Consortium on the Neurocognitive and QOL committees. Her specific research interests include the longitudinal effects of disease and treatment on the CNS, relationship between psychological and biological factors, development of novel assessment tools and pediatric outcome measures, and assessment of quality of life in children with chronic medical conditions.